Sign In
Buy ALNY
$216.98
-2.22 (-1.01%)
At Close: Aug 10, 2026
Andra AP fonden Increases Stake in Alnylam Pharmaceuticals, Inc. $ALNY
04:40am, Saturday, 28'th Feb 2026
Andra AP fonden raised its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 200.0% in the undefined quarter, according to its most recent disclosure with the SEC. The firm owned 20,7
GSK Strikes $1 Billion China RNA Deal
11:43am, Tuesday, 24'th Feb 2026
GSK plc (GSK) is making a calculated bet on next generation gene silencing drugs, signing a licensing agreement worth up to $1 billion with China's Frontier Bio
Alnylam to Webcast Presentation at TD Cowen 46th Annual Health Care Conference
10:00am, Monday, 23'rd Feb 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the TD Cowen
Alnylam Pharmaceuticals, Inc. $ALNY Shares Bought by Lansforsakringar Fondforvaltning AB publ
06:05am, Monday, 23'rd Feb 2026
Lansforsakringar Fondforvaltning AB publ raised its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 5.4% in the third quarter, according to the company in its most recent disclosure
Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development
08:30am, Thursday, 19'th Feb 2026
AUSTIN, Texas, Feb. 19, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Biotechnology mergers and acquisitions (M&As) are increasingly shaped by a clear strategic evolution. Pharmaceutical com
Alnylam Pharmaceuticals, Inc. $ALNY Shares Purchased by Merit Financial Group LLC
04:48am, Wednesday, 18'th Feb 2026
Merit Financial Group LLC increased its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 123.9% during the undefined quarter, according to its most recent Form 13F filing with the
Alnylam Pharmaceuticals, Inc. $ALNY Shares Sold by Skandinaviska Enskilda Banken AB publ
04:15am, Wednesday, 18'th Feb 2026
Skandinaviska Enskilda Banken AB publ decreased its position in Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 6.2% in the third quarter, according to its most recent 13F filing with the Securities a
Why Alnylam Pharmaceuticals Stock Was Soaring on Monday
03:27pm, Tuesday, 17'th Feb 2026
Two analysts weighed in with new evaluations of the biotech. This followed last week's earnings release.
Principal Financial Group Inc. Sells 45,114 Shares of Alnylam Pharmaceuticals, Inc. $ALNY
04:50am, Tuesday, 17'th Feb 2026
Principal Financial Group Inc. cut its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 89.3% during the undefined quarter, according to its most recent filing with the Securities
Aberdeen Group plc Sells 61,228 Shares of Alnylam Pharmaceuticals, Inc. $ALNY
03:16am, Monday, 16'th Feb 2026
Aberdeen Group plc lessened its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 28.0% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commis
Alnylam Hit Hard As Investors Forced To Revise Future Profit Expectations
03:07pm, Friday, 13'th Feb 2026
Alnylam Pharmaceuticals has declined nearly 40% from its all-time high, pressured by near-term TTR market dynamics and longer-term profitability concerns. The TTR business will likely remain "noisy" i
ALNY Q4 Earnings Beat, Sales Miss Despite Y/Y Growth, Stock Down
11:20am, Friday, 13'th Feb 2026
Alnylam tops Q4 earnings estimates but misses on sales despite 85% revenue growth, as booming Amvuttra demand fails to lift shares.
Why Alnylam Pharmaceuticals Stock Slipped Today
07:42pm, Thursday, 12'th Feb 2026
The biotech released its final set of figures for 2025. It had a mixed quarter, despite the recent success of a popular product.
Alnylam Pharmaceuticals, Inc. (ALNY) Q4 2025 Earnings Call Transcript
04:14pm, Thursday, 12'th Feb 2026
Alnylam Pharmaceuticals, Inc. (ALNY) Q4 2025 Earnings Call Transcript
Here's What Key Metrics Tell Us About Alnylam (ALNY) Q4 Earnings
11:01am, Thursday, 12'th Feb 2026
Although the revenue and EPS for Alnylam (ALNY) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Stre
